This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schrier, R D Articles by Oldstone, M B Search for Related Content PubMed PubMed Citation Articles by Schrier, R D Articles by Oldstone, M B

 Previous Article  |  Next Article 

J Virol. 1986 July; 59(1): 127-131

Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity.

ABSTRACT

Peripheral blood mononuclear cells harvested from healthy adults seropositive for human cytomegalovirus (HCMV) and cultured with laboratory strain AD-169 demonstrated human leukocyte antigen-restricted and HCMV-specific killing on target cells infected with either HCMV laboratory strain AD-169 or recent low-passage HCMV isolates. These results indicated that the determinants recognized by cytotoxic T lymphocytes (CTLs) are shared among different strains of HCMV. However, when low-passage isolates, rather than high-passage AD-169 virions, were used to stimulate CTL activity, the lytic response was significantly lower against all targets. Mixing of AD-169 and low-passage HCMV isolates induced low CTL activity. Collectively, the findings suggest that low-passage HCMV isolates have dual effects--antigenic stimulation and immunosuppression--whereas laboratory strain AD-169 is primarily immunogenic. The study of several recent isolates indicated that they varied in their ratio of immunostimulation to suppression, that infectious virus was necessary to produce suppression, and that suppressive isolates did not have to be present at the initiation of culture to exert their suppressive effects.

This article has been cited by other articles:

• Sun, Q., Burton, R. L., Dai, L.-J., Britt, W. J., Lucas, K. G. (2000). B Lymphoblastoid Cell Lines as Efficient APC to Elicit CD8+ T Cell Responses Against a Cytomegalovirus Antigen. J. Immunol. 165: 4105-4111 [Abstract] [Full Text]  
• Sun, Q., Pollok, K. E., Burton, R. L., Dai, L. J., Britt, W., Emanuel, D. J., Lucas, K. G. (1999). Simultaneous Ex Vivo Expansion of Cytomegalovirus and Epstein-Barr Virus-Specific Cytotoxic T Lymphocytes Using B-Lymphoblastoid Cell Lines Expressing Cytomegalovirus pp65. Blood 94: 3242-3250 [Abstract] [Full Text]  
• Noraz, N., Lathey, J. L., Spector, S. A. (1997). Human Cytomegalovirus-Associated Immunosuppression Is Mediated Through Interferon-alpha. Blood 89: 2443-2452 [Abstract] [Full Text]  
• Riddell, SR, Watanabe, K., Goodrich, J., Li, C., Agha, M., Greenberg, P. (1992). Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238-241 [Abstract]